The Latest Breaking News from Jazz

The biotech industry is rapidly growing amid rising private and government investments and technological advancements. Given the solid prospects of the industry, fundamentally strong biotech stocks Amgen (AMGN), Vertex (VRTX), United Therapeutics (UTHR), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) might be ideal long-term investments for steady returns. Keep reading.

The Lakers have reportedly had discussions with the Jazz about a trade that would likely disappoint many fans in Los Angeles.

The actor is expected to play tracks from his debut album, which is set to be released later this year.

SALT LAKE CITY — The Mavericks played the Utah Jazz on Monday night without superstar Luka Doncic … and new trade focal point Kyrie Irving … and trade departees Spencer Dinwiddie and Dorian Finney-Smith … and injured forward Maxi Kleber.

Utah Jazz owner Ryan Smith anticipates the NBA All-Star Game on Feb. 19 will help build Utah into a destination for other major sporting events

Los Angeles is still entertaining the idea of moving their sixth man at the deadline.

A look at the players who could be dealt by Thursday's NBA trade deadline.

Rapidly growing market for personalized medicines and revolutionary technologies like 3D bioprinting is expected to bolster the biotech industry. Moreover, rising government initiatives should support its growth. Hence, quality biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal buys. Continue reading.

The Lakers star crossed another milestone in his career on Tuesday night in the Big Apple.

SALT LAKE CITY — As the final minutes of the Mavericks’ Saturday night game against the Utah Jazz unfolded, Luka Doncic sat at the end of the bench with his arms crossed.

Examining the play of a few notable members of the 2022 NBA draft class.